Irregular bleeding may occur with progestin-only methods, with some users reporting no periods.[47] The progestins drospirenone and desogestrel minimize the androgenic side effects but increase the risks of blood clots and are thus not first line.[48] The perfect use first-year failure rate of injectable progestin is 0.2%; the typical use first failure rate is 6%.[5]